Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00066716
First received: August 6, 2003
Last updated: December 7, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)